GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$210,630	328,972	0		$0.64	Q4 2025
30 Sep 2025	0%	-0%	$277,257	328,972	-40,688	-11%	$0.84	Q3 2025
30 Jun 2025	0%	0%	$251,355	369,660	-9,356	-2.5%	$0.68	Q2 2025
31 Mar 2025	0%	+0%	$274,590	379,016	+20,594		$0.72	Q1 2025
31 Dec 2024	0%	+0%	$342,334	358,422	+20,230	+6%	$0.96	Q4 2024
30 Sep 2024	0%	+0%	$266,420	338,192	+155,337	+85%	$0.79	Q3 2024
30 Jun 2024	0%	+0%	$173,289	182,855	+98,029	+116%	$0.95	Q2 2024
31 Mar 2024	0%	0%	$91,650	84,826	0		$1.08	Q1 2024
31 Dec 2023	0%	0%	$46,672	84,826	0		$0.55	Q4 2023
30 Sep 2023	0%	0%	$179,058	84,826	+100	+0.12%	$2.11	Q3 2023
30 Jun 2023	0%	0%	$221,982	84,726	0		$2.62	Q2 2023
31 Mar 2023	0%	0%	$269,428	84,726	0		$3.18	Q1 2023
31 Dec 2022	0%	0%	$227,000	84,726	+1,137	+1.4%	$2.68	Q4 2022
30 Sep 2022	0%	0%	$243,000	83,589	0		$2.91	Q3 2022
30 Jun 2022	0%	-0%	$244,000	83,589	-58,121	-41%	$2.92	Q2 2022
31 Mar 2022	0%	+0%	$1,001,000	141,710	+7,525	+5.6%	$7.06	Q1 2022
31 Dec 2021	0%	+0%	$2,146,000	134,185	+134,185	NEW	$15.99	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.